---
title: "US IPO Weekly Winners & Losers"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305577995.md"
description: "Anthropic's IPO is live, targeting a $1.2 trillion valuation with an $825 million share offering at $70-$78. The deal could raise over $100 billion including greenshoe and private placement. Other notable IPOs include Windward Bio surging 68% and American Barrick Gold filing for a potential $5 billion carve-out. The Renaissance IPO Index rose 3.4%, outperforming the S&P 500."
datetime: "2026-11-15T17:02:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305577995.md)
  - [en](https://longbridge.com/en/news/305577995.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305577995.md)
generator: "portal-rs"
---

# US IPO Weekly Winners & Losers

**The Anthropic IPO is live.**

After weeks of holding our breath and playing will-they-won’t-they, Anthropic set its proposed deal size, valuation, and timing. For a deal this large, bankers typically leave room to price above the midpoint.

Here’s the current tearsheet:

-   Anthropic PBC (Nasdaq: ANT)
-   Terms: 825 million shares at a range of $70 to $78. Shares are 97% primary.
-   Deal size: $61 billion at $74 midpoint. A high-end pricing, greenshoe, and $26B private placement could put the total raise above $100 billion.
-   Valuation: $1.2 trillion market cap at midpoint.
-   Timing: Pricing Wed. Nov. 18, trading Thu. Nov. 19.
-   Financials: $17B in Q3 revenue, 15% adj. EBITDA margin
-   Roadshow: See it here through Wednesday. Plus Dario Amodei’s fireside chat with Jamie Dimon. Some of his points on AI and exponential growth also appear in my upcoming book.

Amodei repeated his promise to “under-promise and overdeliver” for investors. *Don’t think too hard about that one!*

He also addressed key investor concerns. He argued that Anthropic’s nearly $900 billion in compute commitments could actually *fall short* of expected demand, pointed to Haiku as an answer to lower-cost competitors, and highlighted growth opportunities in pharma and cybersecurity. The company also launched its own spreadsheet tool this week.

More concrete was the latest S-1/A’s $81 billion annualized revenue run rate in October, easing concerns about slowing growth in Q3. Less clear is how much sales and marketing spend it took to get there. (Our IT team certainly appreciates all the free tokens.)

I’m inclined to ignore the elephant in the room. The turmoil surrounding Jensen Huang is a reminder that with expectations for AI so high, virtually any news story can send the sector sharply higher or lower. The headlines will pass, but Anthropic’s IPO is a seminal event in capital markets.

**This week’s IPOs:** Biotech continued its hot streak as asthma-focused Windward Bio (Nasdaq: WWB) soared +68% in its debut. Fast-growing cavity treatment provider vVardis (NYSE: VVVV) broke issue. **Rezera** showed that biotechs aren’t getting a blank check, postponing its deal.

**One company filed**, but it was a big one: American Barrick Gold (NYSE: ABGC) could raise over $5 billion in December. Parent Barrick Mining is hoping that a pure-play carve-out of its gold assets will unlock value. Several filers refreshed their filings with Q3 numbers, betting that Anthropic can reopen the IPO window. The list included neocloud **Nscale**, power equipment supplier **Aggreko**, and beauty brand owner **Wella**.

**The IPO Index** rebounded +3.4% this week, ahead of the S&P 500’s +2.5% gain. The AI infrastructure trade dominated the winners, led by next-gen geothermal producer **Fervo Energy**, up +27.5%. The prior week’s winner, electric aircraft maker **BETA Technologies**, gave up some of its gains, off -14.0%.

The Renaissance IPO Index returned 3.4% last week vs. 2.5% for the S&P 500.

### Related Stocks

- [ANT.US](https://longbridge.com/en/quote/ANT.US.md)
- [WWB.US](https://longbridge.com/en/quote/WWB.US.md)
- [IPO.US](https://longbridge.com/en/quote/IPO.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [B.US](https://longbridge.com/en/quote/B.US.md)

## Related News & Research

- [Anthropic IPO guide: Everything you need to know](https://longbridge.com/en/news/305691440.md)
- [Anthropic’s Valuation Target Has Slipped From $2 Trillion to Under $1.5 Trillion. Here’s Why](https://longbridge.com/en/news/305493732.md)
- [Anthropic's IPO is about six times oversubscribed, Bloomberg News reports](https://longbridge.com/en/news/305371908.md)
- [Arthur Hayes buys crypto risk before Anthropic listing but keeps exits close](https://longbridge.com/en/news/305403579.md)
- [How to interpret Anthropic's IPO pricing in the pre-IPO perpetual contract market?](https://longbridge.com/en/news/305100842.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**